Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ayers

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The Oncologist|May 30, 2003
Clinical application of cDNA microarrays in oncologyLajos Pusztai, Mark Ayers, James Stec, et al.
Cancer Research|July 20, 2007
Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonistMark Ayers, Joseph Fargnoli, Anne Lewin, et al.
Journal of Environmental Health|May 18, 2012
Bacterial amplification and in-place carpet drying: implications for category 1 water intrusion restorationJim Holland, John Banta, Boni Passmore, et al.
Frontiers in Oncology|January 25, 2024
Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancerTorben Steiniche, Jeanette Baehr Georgsen, Peter Meldgaard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as MonotherapyMark Ayers, Michael Nebozhyn, Razvan Cristescu, et al.
Expert Review of Molecular Diagnostics|September 27, 2003
Breast cancer biomarkers and molecular medicineJeffrey S Ross, Gerald P Linette, James Stec, et al.
Expert Review of Molecular Diagnostics|March 6, 2004
Breast cancer biomarkers and molecular medicine: part IIJeffrey S Ross, Gerald P Linette, James Stec, et al.
Cardiology in the Young|January 10, 2014
The importance of small for gestational age in the risk assessment of infants with critical congenital heart diseaseAnthony A Sochet, Mark Ayers, Emilio Quezada, et al.
The Oncologist|August 5, 2003
The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapyJeffrey S Ross, Jonathan A Fletcher, Gerald P Linette, et al.
American Journal of Clinical Pathology|August 10, 2004
HER-2/neu testing in breast cancerJeffrey S Ross, Jonathan A Fletcher, Kenneth J Bloom, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The Oncologist|May 30, 2003
Clinical application of cDNA microarrays in oncologyLajos Pusztai, Mark Ayers, James Stec, et al.
Cancer Research|July 20, 2007
Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonistMark Ayers, Joseph Fargnoli, Anne Lewin, et al.
Journal of Environmental Health|May 18, 2012
Bacterial amplification and in-place carpet drying: implications for category 1 water intrusion restorationJim Holland, John Banta, Boni Passmore, et al.
Frontiers in Oncology|January 25, 2024
Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancerTorben Steiniche, Jeanette Baehr Georgsen, Peter Meldgaard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as MonotherapyMark Ayers, Michael Nebozhyn, Razvan Cristescu, et al.
Expert Review of Molecular Diagnostics|September 27, 2003
Breast cancer biomarkers and molecular medicineJeffrey S Ross, Gerald P Linette, James Stec, et al.
Expert Review of Molecular Diagnostics|March 6, 2004
Breast cancer biomarkers and molecular medicine: part IIJeffrey S Ross, Gerald P Linette, James Stec, et al.
Cardiology in the Young|January 10, 2014
The importance of small for gestational age in the risk assessment of infants with critical congenital heart diseaseAnthony A Sochet, Mark Ayers, Emilio Quezada, et al.
The Oncologist|August 5, 2003
The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapyJeffrey S Ross, Jonathan A Fletcher, Gerald P Linette, et al.
American Journal of Clinical Pathology|August 10, 2004
HER-2/neu testing in breast cancerJeffrey S Ross, Jonathan A Fletcher, Kenneth J Bloom, et al.
Pageof 4